Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas
Authors:
- Nicolas MounierNMNicolas Mounier
- Daniele SimonDSDaniele Simon
- Corinne HaiounCHCorinne Haioun
- Philippe GaulardPGPhilippe Gaulard
- Christian GisselbrechtCGChristian Gisselbrecht
- Issa KhouriIKIssa Khouri
- 1 March 2002
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (5) , 1426-1427
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Impact of High-Dose Chemotherapy on Peripheral T-Cell LymphomasJournal of Clinical Oncology, 2001
- Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte StudyJournal of Clinical Oncology, 2000
- Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and OutcomeBlood, 1997
- Original article: A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the ‘tumor score’Annals of Oncology, 1992